Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes.
Changes in the islet vasculature have been implicated in the regulation of β-cell survival and function during the progression to type 2 diabetes (T2D). Failure of the β-cell to compensate for the increased insulin demand in obesity eventually leads to diabetes; as a result of the complex interplay...
Main Authors: | Payal Shah, Navina Lueschen, Amin Ardestani, Jose Oberholzer, Johan Olerud, Per-Ola Carlsson, Kathrin Maedler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5019443?pdf=render |
Similar Items
-
Correction: Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes.
by: Payal Shah, et al.
Published: (2023-01-01) -
Correction: Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
Published: (2023-01-01) -
Extensive Loss of Islet Mass beyond the First Day after Intraportal Human Islet Transplantation in a Mouse Model
by: Hanna Liljebäck, et al.
Published: (2016-03-01) -
Sustained beta-cell dysfunction but normalized islet mass in aged thrombospondin-1 deficient mice.
by: Carl Johan Drott, et al.
Published: (2012-01-01) -
Commentary: A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
by: Amin Ardestani, et al.
Published: (2020-10-01)